These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 2959449)
21. Comparative metabolic effects of three types of combined oral contraceptive pills in Chinese women. Prasad RN; Liew D; Ratnam SS Contraception; 1989 Jan; 39(1):21-35. PubMed ID: 2521321 [TBL] [Abstract][Full Text] [Related]
22. Comparative pharmacokinetics of two new steroidal estrogens and ethinylestradiol in postmenopausal women. Baumann A; Fuhrmeister A; Brudny-Klöppel M; Draeger C; Bunte T; Kuhnz W Contraception; 1996 Oct; 54(4):235-42. PubMed ID: 8922877 [TBL] [Abstract][Full Text] [Related]
23. Intra- and interindividual variations in contraceptive steroid levels during 12 treatment cycles: no relation to irregular bleedings. Jung-Hoffmann C; Kuhl H Contraception; 1990 Oct; 42(4):423-38. PubMed ID: 2147887 [TBL] [Abstract][Full Text] [Related]
24. Group comparison of serum ethinyl estradiol, SHBG and CBG levels in 83 women using two low-dose combination oral contraceptives for three months. Dibbelt L; Knuppen R; Jütting G; Heimann S; Klipping CO; Parikka-Olexik H Contraception; 1991 Jan; 43(1):1-21. PubMed ID: 1825969 [TBL] [Abstract][Full Text] [Related]
25. Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study. Rosing J; Middeldorp S; Curvers J; Christella M; Thomassen LG; Nicolaes GA; Meijers JC; Bouma BN; Büller HR; Prins MH; Tans G Lancet; 1999 Dec; 354(9195):2036-40. PubMed ID: 10636369 [TBL] [Abstract][Full Text] [Related]
26. Clinical results with subcutaneous implants containing 3-keto desogestrel. Olsson SE; Odlind V; Johansson E Contraception; 1990 Jul; 42(1):1-11. PubMed ID: 2117514 [TBL] [Abstract][Full Text] [Related]
27. The effect of deliberate omission of Trinordiol or Microgynon on the hypothalamo-pituitary-ovarian axis. Smith SK; Kirkman RJ; Arce BB; McNeilly AS; Loudon NB; Baird DT Contraception; 1986 Nov; 34(5):513-22. PubMed ID: 3102162 [TBL] [Abstract][Full Text] [Related]
28. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism. Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499 [TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics and pharmacodynamics of oral contraceptive steroids: factors influencing steroid metabolism. Jung-Hoffman C; Kuhl H Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 2):2183-97. PubMed ID: 2147819 [TBL] [Abstract][Full Text] [Related]
30. Serum lipid and lipoprotein changes induced by new oral contraceptives containing ethinylestradiol plus levonorgestrel or desogestrel. Gaspard UJ; Buret J; Gillain D; Romus MA; Lambotte R Contraception; 1985 Apr; 31(4):395-408. PubMed ID: 3159546 [TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics and serum protein binding of gestodene and 3-keto-desogestrel in women after single oral administration of two different contraceptive formulations. Kuhnz W; Schütt B; Power J; Back DJ Arzneimittelforschung; 1992 Sep; 42(9):1139-41. PubMed ID: 1445482 [TBL] [Abstract][Full Text] [Related]
32. Phase III clinical trial with a new oral contraceptive containing 150 micrograms desogestrel and 20 micrograms ethinylestradiol. Lammers P; op ten Berg M Acta Obstet Gynecol Scand; 1991; 70(6):497-500. PubMed ID: 1837199 [TBL] [Abstract][Full Text] [Related]
33. Effects of oral contraceptive combinations containing levonorgestrel or desogestrel on serum proteins and androgen binding. Bergink EW; Holma P; Pyörälä T Scand J Clin Lab Invest; 1981 Nov; 41(7):663-8. PubMed ID: 6461916 [TBL] [Abstract][Full Text] [Related]
34. Omitting the first oral contraceptive pills of the cycle does not automatically lead to ovulation. Elomaa K; Rolland R; Brosens I; Moorrees M; Deprest J; Tuominen J; Lähteenmäki P Am J Obstet Gynecol; 1998 Jul; 179(1):41-6. PubMed ID: 9704763 [TBL] [Abstract][Full Text] [Related]
35. Clinical performance and endocrine profiles of contraceptive vaginal rings releasing 3-keto-desogestrel and ethinylestradiol. Apter D; Cacciatore B; Stenman UH; Alapiessa U; Assendorp R Contraception; 1990 Sep; 42(3):285-95. PubMed ID: 2149697 [TBL] [Abstract][Full Text] [Related]
36. Comparative studies of 30 micrograms ethinyl estradiol combined with gestodene and desogestrel on blood coagulation, fibrinolysis, and platelets. Daly L; Bonnar J Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):430-7. PubMed ID: 2142580 [TBL] [Abstract][Full Text] [Related]
37. Single- and multiple-dose pharmacokinetics of a low-dose oral contraceptive in women with chronic renal failure undergoing peritoneal dialysis. Price TM; Dupuis RE; Carr BR; Stanczyk FZ; Lobo RA; Droegemueller W Am J Obstet Gynecol; 1993 May; 168(5):1400-6. PubMed ID: 8498419 [TBL] [Abstract][Full Text] [Related]
38. The relative bioavailability of levonorgestrel and ethinyl estradiol administered as a low-dose combination oral contraceptive. Goebelsmann U; Hoffman D; Chiang S; Woutersz T Contraception; 1986 Oct; 34(4):341-51. PubMed ID: 3096634 [TBL] [Abstract][Full Text] [Related]
39. Metabolism of the contraceptive steroid desogestrel by the intestinal mucosa. Madden S; Back DJ; Martin CA; Orme ML Br J Clin Pharmacol; 1989 Mar; 27(3):295-9. PubMed ID: 2524206 [TBL] [Abstract][Full Text] [Related]
40. Long-term treatment of hirsutism: desogestrel compared with cyproterone acetate in oral contraceptives. Porcile A; Gallardo E Fertil Steril; 1991 May; 55(5):877-81. PubMed ID: 1827074 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]